Poelarends Gerrit J, Konings Wil N
Department of Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Kerklaan 30, NL-9751 NN Haren, The Netherlands.
J Biol Chem. 2002 Nov 8;277(45):42891-8. doi: 10.1074/jbc.M206508200. Epub 2002 Aug 14.
The ABC multidrug transporter LmrA of Lactococcus lactis consists of six putative transmembrane segments (TMS) and a nucleotide binding domain. LmrA functions as a homodimer in which the two membrane domains form the solute translocation path across the membrane. To obtain structural information of LmrA a cysteine scanning accessibility approach was used. Cysteines were introduced in the cysteine-less wild-type LmrA in each hydrophilic loop and in TMS 6, and each membrane-embedded aromatic residue was mutated to cysteine. Of the 41 constructed single cysteine mutants, only one mutant, L301C, was not expressed. Most single-cysteine mutants were capable of drug transport and only three mutants, F37C, M299C, and N300C, were inactive, indicating that none of the aromatic residues in the transmembrane regions of LmrA are crucial for substrate binding or transport. Modification of the active mutants with N-ethylmaleimide blocked the transport activity in five mutants (S132C, L174C, S206C, S234C, and L292C). All cysteine residues in external and internal loops were accessible to fluorescein maleimide. The labeling experiments also showed that this thiol reagent cannot cross the membrane under the conditions used and confirmed the presence of six TMSs in each monomeric half of the transporter. Surprisingly, several single cysteines in the predicted TMSs could also be labeled by the bulky fluorescein maleimide molecule, suggesting unrestricted accessibility via an aqueous pathway. The periodicity of fluorescein maleimide accessibility of residues 291 to 308 in TMS 6 showed that this membrane-spanning alpha-helix has one face of the helix exposed to an aqueous cavity along its full-length. This finding, together with the solvent accessibility of 11 of 15 membrane-embedded aromatic residues, indicates that the transmembrane domains of the LmrA transporter form, under nonenergized conditions, an aqueous chamber within the membrane, which is open to the intracellular milieu.
乳酸乳球菌的ABC多药转运蛋白LmrA由六个假定的跨膜区段(TMS)和一个核苷酸结合结构域组成。LmrA以同二聚体形式发挥作用,其中两个膜结构域形成跨膜的溶质转运通道。为了获得LmrA的结构信息,采用了半胱氨酸扫描可及性方法。在无半胱氨酸的野生型LmrA的每个亲水环和TMS 6中引入半胱氨酸,并将每个膜嵌入的芳香族残基突变为半胱氨酸。在构建的41个单半胱氨酸突变体中,只有一个突变体L301C未表达。大多数单半胱氨酸突变体能够进行药物转运,只有三个突变体F37C、M299C和N300C无活性,这表明LmrA跨膜区域中的芳香族残基对底物结合或转运均无关键作用。用N - 乙基马来酰亚胺修饰活性突变体可阻断五个突变体(S132C、L174C、S206C、S234C和L292C)的转运活性。外部和内部环中的所有半胱氨酸残基均能被荧光素马来酰亚胺所接近。标记实验还表明,在所用条件下该硫醇试剂不能穿过膜,并证实了转运蛋白每个单体半部中存在六个TMS。令人惊讶的是,预测TMS中的几个单半胱氨酸也能被庞大的荧光素马来酰亚胺分子标记,这表明通过水相途径具有不受限制的可及性。TMS 6中291至308位残基的荧光素马来酰亚胺可及性的周期性表明,这个跨膜α螺旋的一面在其全长范围内暴露于水腔。这一发现,连同15个膜嵌入芳香族残基中有11个的溶剂可及性,表明在非活化条件下,LmrA转运蛋白的跨膜结构域在膜内形成一个对细胞内环境开放的水腔。